Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Recruiting

InvestigationalNo placebo

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Tulisokibart

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Investigational

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:ICOTROKINRA

Contact Research Centre

Myelofibrosis

Recruiting

Registered drug

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Navtemadlin

Contact Research Centre

Colitis ulcerative

Recruiting

Registered drugNo placebo

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Portugal

Participants:0–17 years
Substances:Filgotinib

Contact Research Centre

Crohn's disease

Recruiting

InvestigationalNo placebo

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:ABBV-8736

Contact Research Centre

Muscle spasticity

Not recruiting

Registered drug

Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Botulinum Toxin Type A - Haemagglutinin Complex

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Crohn's disease

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Ozanimod

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Registered drug

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Tulisokibart

Contact Research Centre

Find therapies in clinical trials near you

20 trials match your criteria

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Cardiovascular disorder+1

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Crohn's disease

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Colitis ulcerative

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Myelofibrosis

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Colitis ulcerative

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Crohn's disease

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

Muscle spasticity

Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

Sjogren's syndrome

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Crohn's disease

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

Metabolic dysfunction-associated steatohepatitis+1

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Crohn's disease

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.